| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/30/2012 | CN102477382A 一种男士保健酒 One kind of men's health wine |
| 05/30/2012 | CN102477378A 一种壮阳保健酒 An aphrodisiac health wine |
| 05/30/2012 | CN102477370A 一种补肾保健酒 One kind of kidney health wine |
| 05/30/2012 | CN102477033A 苯并噻酚类化合物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Benzothiazole phenolic compounds and their preparation for prevention and / or treatment of osteoporosis, breast cancer medicament for use in |
| 05/30/2012 | CN102475848A 肾病愈康片 Nephrotic more Tablets |
| 05/30/2012 | CN102475816A 一种治疗前列腺肥大的方剂 An enlarged prostate treatment prescription |
| 05/30/2012 | CN102475812A 一种治疗前列腺增生的方剂 A prescription treatment of benign prostatic hyperplasia |
| 05/30/2012 | CN102475788A 一种兽用止痢散 One kind of veterinary Zhilishen scattered |
| 05/30/2012 | CN102475777A 尿石消 Elimination of urinary stones |
| 05/30/2012 | CN102475765A 一种改善肾功能并抑制肾组织纤维化的中药组合物 A method of improving renal function and inhibit renal fibrosis herbal compositions |
| 05/30/2012 | CN102475764A 肾康注射液的制备方法 Shenkang injection preparation |
| 05/30/2012 | CN102475763A 一种治疗慢性肾衰的肾康滴丸及其制备方法 A method of treating chronic renal failure Shenkang dropping pills and its preparation method |
| 05/30/2012 | CN102475762A 一种治疗慢性肾衰的肾康口服液体复方制剂及其制备方法 A method of treating chronic renal failure Shenkang oral liquid compound and its preparation method |
| 05/30/2012 | CN102475761A 一种治疗慢性肾衰的肾康口服固体复方制剂及其制备方法 A method of treating chronic renal failure Shenkang oral solid compound and its preparation method |
| 05/30/2012 | CN102475760A 一种治疗慢性肾功能衰竭的肾康复方制剂及其制备方法 A kidney rehabilitation party and its preparation method of treatment of chronic renal failure |
| 05/30/2012 | CN102475759A Shenkang sodium chloride injection for treating chronic renal failure and preparation method of Shenkang sodium chloride injection |
| 05/30/2012 | CN102475758A 一种治疗慢性肾衰的肾康片剂及其制备方法 A method of treating chronic renal failure Shenkang tablet and its preparation method |
| 05/30/2012 | CN102475757A 一种治疗慢性肾衰的肾康外用复方制剂及其制备方法 A method of treating chronic renal failure Shenkang topical compound and its preparation method |
| 05/30/2012 | CN102475756A 一种治疗慢性肾功能衰竭的肾康注射复方制剂及其制备方法 A Shenkang injection of compound and its preparation method of treatment of chronic renal failure |
| 05/30/2012 | CN102475755A 一种治疗慢性肾衰的肾康气雾剂及其制备方法 A method of treating chronic renal failure Shenkang aerosol and its preparation method |
| 05/30/2012 | CN102475754A 一种治疗慢性肾衰的肾康软胶囊及其制备方法 A method of treating chronic renal failure Shenkang soft capsule and its preparation method |
| 05/30/2012 | CN102475753A 一种治疗慢性肾衰的肾康贴剂及其制备方法 A method of treating chronic renal failure Shenkang patch and its preparation method |
| 05/30/2012 | CN102475731A 治疗小儿(轮状病毒、痢疾及疟疾)疾病分子苗药原料 Treatment of children (rotavirus, diarrhea and malaria) disease molecular Miao medicine raw materials |
| 05/30/2012 | CN102475714A 壳寡糖单一化合物在免疫增强药物中的应用 Oligochitosan single compounds in immune-enhancing drugs in |
| 05/30/2012 | CN102475703A Anti-Acinetobacter baumannii drug combination and application thereof |
| 05/30/2012 | CN102475690A 内含盐酸阿夫唑嗪的缓释片剂 Containing alfuzosin hydrochloride sustained-release tablets |
| 05/30/2012 | CN101972323B Quality analysis method for loins-strengthening and kidney-invigorating oral liquid |
| 05/30/2012 | CN101912398B Medicament for treating urinary tract infection |
| 05/30/2012 | CN101869629B Traditional Chinese medicine for treating renal calculus |
| 05/30/2012 | CN101829270B Traditional Chinese medicine preparation for treating chronic renal failure and preparation method |
| 05/30/2012 | CN101780067B Pharmaceutical composition for treating diabetic nephropathy and preparation method and application |
| 05/30/2012 | CN101766678B Application of total flavonoid in astragalus to preparing medicaments for preventing and controlling diabetes and nephropathy |
| 05/30/2012 | CN101732440B Raspberry extract and raspberry element obtain by separation thereof and application thereof |
| 05/30/2012 | CN101670004B Composition for prophylaxis or treatment of urinary system infection |
| 05/30/2012 | CN101646678B Heteroaryl derivative |
| 05/30/2012 | CN101618118B Application of Chinese medicinal composition in preparing medicament for treating cystitis |
| 05/30/2012 | CN101618110B Application of Chinese medicinal composition in preparing medicament for treating urinary calculi |
| 05/30/2012 | CN101601741B Diuretic medicine |
| 05/30/2012 | CN101590048B Pharmaceutical composition containing amlodipine and dutasteride |
| 05/30/2012 | CN101563320B [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 05/30/2012 | CN101511799B Cyclic amine compound |
| 05/30/2012 | CN101457198B Tuberfleeceflower wine and preparation method thereof |
| 05/30/2012 | CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 05/30/2012 | CN101161262B A medicine for treating chronic renal failure and its preparing method |
| 05/30/2012 | CN101028282B Use of low-molecular weight phaeophytin polyose sulfate in preparation of medicine for treating kidney disease |
| 05/29/2012 | US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 05/29/2012 | US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 05/29/2012 | US8187634 Process for the preparation of sevelamer hydrochloride and formulation thereof |
| 05/29/2012 | CA2496127C Piperidinyl compounds that selectively bind integrins |
| 05/29/2012 | CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 05/24/2012 | WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | WO2012065958A1 Method of treating contrast-induced nephropathy |
| 05/24/2012 | US20120129930 Ketone compounds and compositions for cholesterol management and related uses |
| 05/24/2012 | US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 05/24/2012 | US20120129890 Indole derivative or pharmaceutically acceptable salt thereof |
| 05/24/2012 | US20120129886 Metalloenzyme inhibitor compounds |
| 05/24/2012 | US20120129878 Tablet |
| 05/24/2012 | US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129867 Inhibitors of protein kinases |
| 05/24/2012 | US20120129863 Chymase inhibitors |
| 05/24/2012 | US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
| 05/24/2012 | US20120129857 Substituted sodium 1H-pyrazol-5-olate |
| 05/24/2012 | US20120129853 Methods of treatment using selective bcl-2 inhibitors |
| 05/24/2012 | US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 05/24/2012 | US20120129829 Novel indole modulators of s1p receptors |
| 05/24/2012 | US20120129819 Gel compositions for administration of pharmaceutically active compounds |
| 05/24/2012 | US20120129814 Novel phosphonic acids as s1p receptor modulators |
| 05/24/2012 | US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129778 Ligand that bind tgf-beta receptor rii |
| 05/24/2012 | US20120129776 Bioactive peptides and method of using same |
| 05/24/2012 | US20120129774 Kinin b1 receptor peptide agonists and uses thereof |
| 05/24/2012 | US20120128773 Desfesoterodine in the form of a tartaric acid salt |
| 05/24/2012 | US20120128762 Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder Disorders |
| 05/24/2012 | US20120128686 Thienopyrimidines for pharmaceutical compositions |
| 05/24/2012 | US20120128679 Human Antibodies to the Glucagon Receptor |
| 05/24/2012 | US20120128674 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 05/24/2012 | US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence |
| 05/24/2012 | DE102010051776A1 Composition, useful to treat urinary tract diseases, preferably cystitis comprises a carbon with specified range of charcoal, which carried by an aqueous vector to become a carbon-basic aqueous vector |
| 05/24/2012 | DE102010044131A1 Substituiertes Natrium-1H-pyrazol-5-olat Substituted sodium-1H-pyrazol-5-olate |
| 05/24/2012 | CA2817784A1 Method of treating contrast-induced nephropathy |
| 05/23/2012 | EP2455096A1 Oxidized protein hydrolase activity enhancer |
| 05/23/2012 | EP2455082A1 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications |
| 05/23/2012 | EP2453893A1 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
| 05/23/2012 | EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 05/23/2012 | CN202223586U Traditional Chinese medicine pulp for treating combined gallbladder channel tissue and kidney channel tissue diseases and package thereof |
| 05/23/2012 | CN102471333A 新型噻吩甲酰胺衍生物及其药物用途 Novel thiophene carboxamide derivatives and pharmaceutical use |
| 05/23/2012 | CN102471248A 用于递送1，3-丙二磺酸的方法、化合物和组合物 Methods for the delivery of 1,3-propanediol acid, the compounds and compositions |
| 05/23/2012 | CN102470153A 氧化蛋白水解酶活性增强剂 Oxidation proteolytic activity enhancer |
| 05/23/2012 | CN102470110A 包含托特罗定的透皮组合物 Comprising the transdermal composition of tolterodine |
| 05/23/2012 | CN102464631A 哌嗪取代的1,3-二取代脲类化合物及哌嗪取代的酰胺类化合物及其制备方法和用途 Piperazine-substituted 1,3-di-substituted urea compounds and piperazine substituted amides and their preparation and use |
| 05/23/2012 | CN102462837A Anti-inflammatory composition |
| 05/23/2012 | CN102462813A 一种治疗尿毒症的中药缓释剂 A method of treating uremia medicine release agent |
| 05/23/2012 | CN102462778A 一种抗衰老补酒 An anti-aging tonic |
| 05/23/2012 | CN102462771A 一种中药鱼腥草注射液的制备方法 A traditional Chinese medicine preparation Houttuynia injection |
| 05/23/2012 | CN102462725A 一种苦瓜提取物微丸及其制备方法 One kind of bitter melon extract pellets and its preparation method |
| 05/23/2012 | CN102462715A 一种红参提取物微丸及其制备方法 One kind of red ginseng extract pellets and its preparation method |
| 05/23/2012 | CN102462694A 氢气在制备预防肾结石药品和保健饮品中的应用 Hydrogen prevent kidney stones in the preparation of drugs and health drinks |
| 05/23/2012 | CN102462674A 姜黄素及其衍生物在制备治疗人巨细胞病毒感染药物中的应用 Curcumin and its derivatives in the preparation of the treatment of human cytomegalovirus infection medicine |